drugset / Trial / NCT01014559

Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients

NCT01014559

Phase 3 Terminated 225 enrolled Mundipharma SAS
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this trial is to study the efficacy of oxycodone/naloxone prolonged release tablets (OXN PR), compared to oxycodone prolonged release tablets (Oxy PR), for the reduction of the intensity of opioid-induced constipation symptoms in patients treated for cancer or non-cancer pain.

Timeline

Start
2010-02
Primary completion
2011-06
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naloxone Small molecule
Comparator Oxycodone Other / unclassified

Indications